Microbot Medical Inc.
MBOT
$2.23
-$0.26-10.44%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.55% | -5.87% | 10.08% | 20.06% | 18.44% |
| Total Depreciation and Amortization | -14.15% | -3.85% | -11.01% | 2.83% | 3.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -60.89% | 148.76% | 117.84% | 106.76% | 97.54% |
| Change in Net Operating Assets | 187.44% | -1,147.27% | -73.59% | -55.22% | -490.35% |
| Cash from Operations | -3.45% | 2.38% | 25.03% | 34.01% | 26.11% |
| Capital Expenditure | 24.24% | 66.67% | -156.25% | 30.88% | 60.71% |
| Sale of Property, Plant, and Equipment | -- | -200.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.13% | 164.13% | 115.23% | -147.07% | 153.46% |
| Cash from Investing | -22.10% | 163.31% | 113.23% | -134.15% | 151.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 18.11% | -53.78% | -59.51% | 110.82% | 55.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 21.01% | -53.10% | -60.97% | 107.10% | 51.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32,400.00% | 71.82% | -103.25% | 88.17% | 99.98% |